EpiBone, Inc. Secures Funding Round Led by Kendall Capital Partners to Accelerate Global Expansion of Clinical Trials
NEW YORK, Nov. 8, 2024 /PRNewswire/ — EpiBone, Inc., a leading regenerative medicine company at the forefront of skeletal repair, announces the successful close of a convertible note funding round led by Kendall Capital Partners, with participation…